Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
 
Home
 


Online Report Subscribers, Click Here


Pricing and Ordering Information

European Markets for Current and Emerging Biomaterial-Based Arthroscopy Products
July 2006, 331 pages
Report #A316

The European biomaterials-based arthroscopy products market, valued at approximately $550.3 million in 2005, offers considerable commercial potential.  Due to the continuing growth and aging of the European population, there will be a steady demand for both new, emerging biomaterials-based arthroscopy products, as well as older, established products.

 

Viscosupplementation products represented the largest segment of the European biomaterials-based arthroscopy products market in 2005, capturing approximately $322.8 million or 58.7% of total sales; bioresorbable tissue fixation products represented the second-largest segment of the overall market in 2005, with approximately $102.9 million or 18.6% of total sales.  By the year 2010, European biomaterials-based arthroscopic surgery products revenues are projected to reach approximately $945.1 million, with most of this activity attributable to sales of viscosupplementation products.  Over the forecast period covered by this report, sales of viscosupplementation products are expected to increase at a brisk compound annual rate of 10.2%, reaching approximately $526.4 million in the year 2010.

 

This dynamic report from Medtech Insight includes analyses of products and technologies, current and forecast markets, competitors, and opportunities in European markets for biomaterial-based arthroscopic surgery products.

 

Covered topics in this report include arthroscopic suturing devices, autologous cultured chondrocytes, bioresorbable tissue fixation devices, and viscosupplementation products.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS AND LIST OF EXHIBITS

 

EXECUTIVE SUMMARY

i.      European Healthcare Markets

ii.     Biomaterials in Arthroscopic Surgery Applications

iii.    Bioresorbable Tissue Fixation Devices

iv.    Arthroscopic Suturing Devices

a.  Suture Anchors

b.  Meniscal Repair Devices

v.     Viscosupplementation Products

vi.    Autologous Cultured Chondrocytes

 

Exhibit ES-1:    Europe, Biomaterials-Based Arthroscopy Products, Market Forecast, By Segment, 2004-2010

Exhibit ES-2:    European Union, Population Statistics Comparison, 1995 and 2005

Exhibit ES-3:    Europe, Bioresorbable Fixation Products, Combined Market Forecast, 2004-2010

Exhibit ES-4:    Europe, Bioresorbable Fixation Products, Market Forecast, By Country, 2004-2010

Exhibit ES-5:    Europe, Arthroscopic Suturing Devices, Market Forecast, By Country, 2004-2010

Exhibit ES-6:    Europe, Arthroscopic Suture Anchors, Combined Market Forecast, 2004-2010

Exhibit ES-7:    Europe, Meniscal Repair Devices, Combined Market Forecast, 2004-2010

Exhibit ES-8:    Europe, Viscosupplementation, Combined Market Forecast, 2004-2010

Exhibit ES-9:    Europe, Viscosupplementation Products, Market Forecast, By Country, 2004-2010

Exhibit ES-10:   Europe, Autologous Cultured Chondrocytes, Combined Market Forecast, 2004-2010

Exhibit ES-11:   Europe, Autologous Cultured Chondrocytes, Market Forecast, By Country, 2004-2010

 

1. EUROPEAN HEALTHCARE MARKET OVERVIEW

1.1 The European Union

1.1.1 A Common Currency

1.1.2 Regulatory Policies

1.1.3 Reimbursement

1.1.4 Factors Affecting Healthcare Delivery

1.1.4.1 Aging Population

1.1.4.2 Cost Containment

1.1.4.3 Industry Consolidation

1.1.4.4 Managed Care

1.1.5 Healthcare Spending

1.1.6 Hospital Services

1.2 Selected European National Healthcare Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform

1.2.1.2 Hospital Services

1.2.1.3 Medical Device Reimbursement

1.2.2 Germany

1.2.2.1 Healthcare Organization and Reform

1.2.2.2 Hospital Services

1.2.2.3 Medical Device Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform

1.2.3.2 Hospital Services

1.2.3.3 Medical Device Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform

1.2.4.2 Hospital Services

1.2.4.3 Medical Device Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform

1.2.5.2 Hospital Services

1.2.5.3 Medical Device Reimbursement

1.2.6 Rest of Europe

1.2.6.1 Healthcare Organization and Reform

 

Exhibit 1-1:      European Union, Medical Devices Risk Classification System

Exhibit 1-2:      European Union, Population Statistics Comparison, 1995 and 2005

Exhibit 1-3:      France, Selected National Healthcare Statistics

Exhibit 1-4:      Germany, Selected National Healthcare Statistics

Exhibit 1-5:      Italy, Selected National Healthcare Statistics

Exhibit 1-6:      Spain, Selected National Healthcare Statistics

Exhibit 1-7:      United Kingdom, Selected National Healthcare Statistics

Exhibit 1-8:      2003, Key Health System Characteristics of New European Union Member States

 

2. MUSCULOSKELETAL SYSTEM OVERVIEW

2.1 Bone Structure and Function

2.1.1 Cellular Framework

2.1.1.1 Osteoblasts

2.1.1.2 Osteocytes

2.1.1.3 Osteoclasts

2.1.1.4 Osteogenesis

2.1.2 Bone Tissue

2.1.2.1 Cancellous and Cortical Bone Tissue

2.1.2.2 Bone Marrow

2.1.3 Bone Anatomy

2.1.3.1 Diaphysis and Epiphysis

2.1.3.2 Endosteum

2.1.3.3 Periosteum

2.1.4 Joint Components

2.1.4.1 Cartilage

2.1.4.1.1 Elastic Cartilage

2.1.4.1.2 Fibrocartilage

2.1.4.1.3 Hyaline Cartilage

2.1.4.2 Bursae

2.1.4.3 Joint Cavity

2.1.4.4 Menisci

2.1.4.5 Synovial Membrane and Fluid

2.1.4.6 Ligaments and Tendons

2.1.4.7 Muscles

2.1.5 Joint Structures

2.1.5.1 Ankle

2.1.5.2 Digits

2.1.5.3 Elbow

2.1.5.4 Hip

2.1.5.5 Knee

2.1.5.6 Shoulder

2.1.5.7 Wrist

2.1.6 Bone Formation and Remodeling

2.1.6.1 In the Fetus

2.1.6.2 In Childhood

2.1.6.3 In Adulthood

2.1.6.4 In Old Age

2.1.6.5 Mechanical Stress and Wolff’s Law

2.1.7 Factors Affecting Bone Physiology

2.1.7.1 Age

2.1.7.2 Gender

2.1.7.3 Genetic Disposition

2.1.7.4 Hormonal Activity

2.1.7.5 Physical Activity

2.1.7.6 Cigarette Smoking

2.1.7.7 Alcohol and Caffeine Intake

2.1.7.8 Nutritional Deficiencies

2.2 Joint Structure and Function

2.2.1 Types of Joints

2.2.1.1 Synarthroses

2.2.1.2 Amphiarthroses

2.2.1.3 Diarthroses

2.2.1.3.1 Ball-and-Socket

2.2.1.3.2 Condyloid

2.2.1.3.3 Hinge

2.2.1.3.4 Gliding

2.2.1.3.5 Pivot

2.2.2 Arthritis

2.2.2.1 Osteoarthritis

2.2.2.2 Rheumatoid Arthritis

2.3 Management of Joint Disorders

2.3.1 Joint Replacement

2.3.1.1 Dislocation

2.3.1.2 Ligament and Tendon Injuries

2.3.1.3 Meniscal Injuries

2.3.2 Arthroscopy

 

Exhibit 2-1:      Illustration of Bone Tissue

Exhibit 2-2:      Types of Cartilage

 

3. BIOMATERIALS IN ORTHOPEDIC AND ARTHROSCOPIC SURGERY APPLICATIONS

3.1 Introduction to Biomaterials

3.1.1 Definition of Biomaterials

3.1.2 Biomaterial Sources

3.1.2.1 Biomaterials Derived from Living Tissues

3.1.2.2 Synthetic Biomaterials

3.1.2.2.1 Organic

3.1.2.2.2 Inorganic

3.1.2.3 Hybrid Biomaterials

3.1.3 Properties of Biomaterials

3.1.3.1 Nonresorbable Biomaterials

3.1.3.2 Resorbable and Soluble Biomaterials

3.1.3.3 Host Tissue Response

3.1.4 Tissue Engineering and the Use of Biomaterial Scaffolds

3.1.4.1 Scaffolds for Bone Tissue Regeneration/Repair

3.1.4.2 Scaffolds for Cartilage Tissue Regeneration/Repair

3.1.4.3 Scaffolds for Meniscal Tissue Regeneration/Repair

3.1.4.4 Tissue Engineering Techniques and Bone Growth Factors

3.1.4.5 Tissue Engineering Techniques and Gene Therapy

3.2 Reconstructive Materials

3.2.1 Metals

3.2.1.1 Cobalt Alloys

3.2.1.1.1 Structure and Properties

3.2.1.1.2 Host Tissue Response

3.2.1.1.3 Advantages and Disadvantages

3.2.1.2 Stainless Steel Alloys

3.2.1.2.1 Structure and Properties

3.2.1.2.2 Host Tissue Response

3.2.1.2.3 Advantages and Disadvantages

3.2.1.3 Titanium Alloys

3.2.1.3.1 Structure and Properties

3.2.1.3.2 Host Tissue Response

3.2.1.3.3 Advantages and Disadvantages

3.2.2 Ceramics

3.2.2.1 Aluminum Oxides

3.2.2.1.1 Structure and Properties

3.2.2.2 Hydroxyapatite/Calcium Phosphates

3.2.2.3 Structure and Properties

3.2.2.4 Bioactive Glasses

3.2.2.4.1 Structure and Properties

3.2.2.4.2 Host Tissue Response

3.2.2.4.3 Advantages and Disadvantages

3.2.3 Polymers

3.2.3.1 Carbon Fiber

3.2.3.1.1 Structure and Properties

3.2.3.2 Silicone Rubber

3.2.3.2.1 Structure and Properties

3.2.3.3 Polyethylene

3.2.3.3.1 Structure and Properties

3.2.3.4 Polytetrafluoroethylene

3.2.3.4.1 Structure and Properties

3.2.3.5 Polyurethanes

3.2.3.5.1 Structure and Properties

3.2.3.6 Ultra-High Molecular-Weight Polyethylene

3.2.3.6.1 Structure and Properties

3.2.3.7 Host Tissue Response

3.2.3.8 Advantages and Disadvantages

3.3 Resorbable Materials

3.3.1 Polyglycolic Acid

3.3.2 Polylactic Acid

3.3.3 Copolymers

 

Exhibit 3-1:      2006, Selected Synthetic Biomaterials Used in Tissue Engineering and Organ Replacement/Regeneration Applications

Exhibit 3-2:      American Society for Testing and Materials, Document 1418, Silicone Rubber Classifications

 

4. ARTHROSCOPIC SURGERY PRODUCTS MARKETS

4.1 Arthroscopic Surgery

4.1.1 Articular Surface Repair

4.1.2 Ligament Repair

4.1.3 Meniscal Repair

4.1.4 Tendon Repair

4.2 Bioresorbable Tissue Fixation Devices

4.2.1 Indications for Use

4.2.2 Products/Technologies

4.2.3 Market Forecasts

4.2.3.1 France

4.2.3.2 Germany

4.2.3.3 Italy

4.2.3.4 Spain

4.2.3.5 United Kingdom

4.2.3.6 Rest of Europe

4.2.4 Competitive Analysis

4.2.4.1 France

4.2.4.2 Germany

4.2.4.3 Italy

4.2.4.4 Spain

4.2.4.5 United Kingdom

4.2.4.6 Rest of Europe

4.3 Arthroscopic Suturing Devices

4.3.1 Suture Anchors

4.3.1.1 Products/Technologies

4.3.1.2 Market Analysis

4.3.2 Meniscal Repair Devices

4.3.2.1 Products/Technologies

4.3.2.2 Market Analysis

4.3.3 Market Forecasts

4.3.3.1 France

4.3.3.2 Germany

4.3.3.3 Italy

4.3.3.4 Spain

4.3.3.5 United Kingdom

4.3.3.6 Rest of Europe

4.3.4 Competitive Analysis

4.3.4.1 France

4.3.4.2 Germany

4.3.4.3 Italy

4.3.4.4 Spain

4.3.4.5 United Kingdom

4.3.4.6 Rest of Europe

4.4 Viscosupplementation Products

4.4.1 Hyaluronic Acid Formulations

4.4.2 Products/Technologies

4.4.3 Market Forecasts

4.4.3.1 France

4.4.3.2 Germany

4.4.3.3 Italy

4.4.3.4 Spain

4.4.3.5 United Kingdom

4.4.3.6 Rest of Europe

4.4.4 Competitive Analysis

4.4.4.1 France

4.4.4.2 Germany

4.4.4.3 Italy

4.4.4.4 Spain

4.4.4.5 United Kingdom

4.4.4.6 Rest of Europe

4.5 Autologous Cultured Chondrocytes

4.5.1 Indications for Use

4.5.2 Harvesting Procedures

4.5.3 Culturing Procedures

4.5.4 Implantation Procedures

4.5.5 Products/Technologies

4.5.6 Market Forecasts

4.5.6.1 France

4.5.6.2 Germany

4.5.6.3 Italy

4.5.6.4 Spain

4.5.6.5 United Kingdom

4.5.6.6 Rest of Europe

4.5.7 Competitive Analysis

4.5.7.1 France

4.5.7.2 Germany

4.5.7.3 Italy

4.5.7.4 Spain

4.5.7.5 United Kingdom

4.5.7.6 Rest of Europe

 

Exhibit 4-1:      Treatment Options for Anterior Cruciate Ligament Repair

Exhibit 4-2:      Treatment Options for Meniscal Injury Repair

Exhibit 4-3:      Types of Bioresorbable Fixation Devices

Exhibit 4-4:      2006, Selected Bioresorbable Bone Screws, Nails, Pins, and Tacks

Exhibit 4-5:      2006, Selected Bioresorbable Interference Screws

Exhibit 4-6:      Europe, Bioresorbable Fixation Products, Combined Market Forecast, 2004-2010

Exhibit 4-7:      Europe, Bioresorbable Fixation Products, Market Forecast, By Country, 2004-2010

Exhibit 4-8:      France, Bioresorbable Fixation Products, Market Forecast, 2004-2010

Exhibit 4-9:      Germany, Bioresorbable Fixation Products, Market Forecast, 2004-2010

Exhibit 4-10:     Italy, Bioresorbable Fixation Products, Market Forecast, 2004-2010

Exhibit 4-11:     Spain, Bioresorbable Fixation Products, Market Forecast, 2004-2010

Exhibit 4-12:     United Kingdom, Bioresorbable Fixation Products, Market Forecast, 2004-2010

Exhibit 4-13:     Rest of Europe, Bioresorbable Fixation Products, Market Forecast, 2004-2010

Exhibit 4-14:     2005, Europe, Bioresorbable Fixation Products Market, Share by Supplier

Exhibit 4-15:     2005, France, Bioresorbable Fixation Products Market, Share by Supplier

Exhibit 4-16:     2005, Germany, Bioresorbable Fixation Products Market, Share by Supplier

Exhibit 4-17:     2005, Italy, Bioresorbable Fixation Products Market, Share by Supplier

Exhibit 4-18:     2005, Spain, Bioresorbable Fixation Products Market, Share by Supplier

Exhibit 4-19:     2005, United Kingdom, Bioresorbable Fixation Products Market, Share by Supplier

Exhibit 4-20:     2005, Rest of Europe, Bioresorbable Fixation Products Market, Share by Supplier

Exhibit 4-21:     2006, Selected Bioresorbable Suture Anchors

Exhibit 4-22:     Europe, Arthroscopic Suture Anchors, Combined Market Forecast, 2004-2010

Exhibit 4-23:     2006, Selected Bioresorbable Meniscal Repair Devices

Exhibit 4-24:     Europe, Meniscal Repair Devices, Combined Market Forecast, 2004-2010

Exhibit 4-25:     Europe, Arthroscopic Suturing Devices, Market Forecast, By Country, 2004-2010

Exhibit 4-26:     France, Arthroscopic Suturing Devices, Market Forecast, 2004-2010

Exhibit 4-27:     Germany, Arthroscopic Suturing Devices, Market Forecast, 2004-2010

Exhibit 4-28:     Italy, Arthroscopic Suturing Devices, Market Forecast, 2004-2010

Exhibit 4-29:     Spain, Arthroscopic Suturing Devices, Market Forecast, 2004-2010

Exhibit 4-30:     United Kingdom, Arthroscopic Suturing Devices, Market Forecast, 2004-2010

Exhibit 4-31:     Rest of Europe, Arthroscopic Suturing Devices, Market Forecast, 2004-2010

Exhibit 4-32:     2005, Europe, Arthroscopic Suturing Devices Market, Share by Supplier

Exhibit 4-33:     2005, France, Arthroscopic Suturing Devices Market, Share by Supplier

Exhibit 4-34:     2005, Germany, Arthroscopic Suturing Devices Market, Share by Supplier

Exhibit 4-35:     2005, Italy, Arthroscopic Suturing Devices Market, Share by Supplier

Exhibit 4-36:     2005, Spain, Arthroscopic Suturing Devices Market, Share by Supplier

Exhibit 4-37:     2005, United Kingdom, Arthroscopic Suturing Devices Market, Share by Supplier

Exhibit 4-38:     2005, Rest of Europe, Arthroscopic Suturing Devices Market, Share by Supplier

Exhibit 4-39:     2006, Selected Current and Emerging Viscosupplementation Products

Exhibit 4-40:     Europe, Viscosupplementation, Combined Market Forecast, 2004-2010

Exhibit 4-41:     Europe, Viscosupplementation Products, Market Forecast, By Country, 2004-2010

Exhibit 4-42:     France, Viscosupplementation Products, Market Forecast, 2004-2010

Exhibit 4-43:     Germany, Viscosupplementation Products, Market Forecast, 2004-2010

Exhibit 4-44:     Italy, Viscosupplementation Products, Market Forecast, 2004-2010

Exhibit 4-45:     Spain, Viscosupplementation Products, Market Forecast, 2004-2010

Exhibit 4-46:     United Kingdom, Viscosupplementation Products, Market Forecast, 2004-2010

Exhibit 4-47:     Rest of Europe, Viscosupplementation Products, Market Forecast, 2004-2010

Exhibit 4-48:     2005, Europe, Viscosupplementation Products Market, Share by Supplier

Exhibit 4-49:     2005, France, Viscosupplementation Products Market, Share by Supplier

Exhibit 4-50:     2005, Germany, Viscosupplementation Products Market, Share by Supplier

Exhibit 4-51:     2005, Italy, Viscosupplementation Products Market, Share by Supplier

Exhibit 4-52:     2005, Spain, Viscosupplementation Products Market, Share by Supplier

Exhibit 4-53:     2005, United Kingdom, Viscosupplementation Products Market, Share by Supplier

Exhibit 4-54:     2005, Rest of Europe, Viscosupplementation Products Market, Share by Supplier

Exhibit 4-55:     2006, Selected Autologous Cultured Chondrocyte Products

Exhibit 4-56:     Europe, Autologous Cultured Chondrocytes, Combined Market Forecast, 2004-2010

Exhibit 4-57:     Europe, Autologous Cultured Chondrocytes, Market Forecast, By Country, 2004-2010

Exhibit 4-58:     France, Autologous Cultured Chondrocytes, Market Forecast, 2004-2010

Exhibit 4-59:     Germany, Autologous Cultured Chondrocytes, Market Forecast, 2004-2010

Exhibit 4-60:     Italy, Autologous Cultured Chondrocytes, Market Forecast, 2004-2010

Exhibit 4-61:     Spain, Autologous Cultured Chondrocytes, Market Forecast, 2004-2010

Exhibit 4-62:     United Kingdom, Autologous Cultured Chondrocytes, Market Forecast, 2004-2010

Exhibit 4-63:     Rest of Europe, Autologous Cultured Chondrocytes, Unit Volumes and Market Forecast, 2004-2010

Exhibit 4-64:     2005, Europe, Autologous Cultured Chondrocytes Market, Share by Supplier

Exhibit 4-65:     2005, France, Autologous Cultured Chondrocytes Market, Share by Supplier

Exhibit 4-66:     2005, Germany, Autologous Cultured Chondrocytes Market, Share by Supplier

Exhibit 4-67:     2005, Italy, Autologous Cultured Chondrocytes Market, Share by Supplier

Exhibit 4-68:     2005, Spain, Autologous Cultured Chondrocytes Market, Share by Supplier

Exhibit 4-69:     2005, United Kingdom, Autologous Cultured Chondrocytes Market, Share by Supplier

Exhibit 4-70:     2005, Rest of Europe, Autologous Cultured Chondrocytes Market, Share by Supplier

 

5. COMPANY PROFILES

5.1     Anika Therapeutics, Inc.

5.2     ARS ARTHRO AG

5.3     Arthrex, Inc.

5.4     Biocomposites LTD

5.5     Biomet, Inc.

5.6     Bioniche Life Sciences, Inc.

5.7     BioTissue Technologies GmbH/The BioTissue Group

5.8     co.don AG

5.9     ConMed Corporation

5.10    Genzyme Corporation

5.11    Interface Biotech AS

5.12    Johnson & Johnson

5.13    Regeneration Technologies, Inc.

5.14    Smith & Nephew PLC

5.15    Stryker Corporation

5.16    TETEC AG

5.17    Tyco International LTD

 

APPENDIX:  COMPANY LISTING

 

Copyright 2006, Medtech Insight, LLC


Ordering Information

Title

Report # Publication
Date
List Price

European Markets for Current and Emerging Biomaterial-Based Arthroscopy Products

A316

July
2006

$4,550*

 

*The pdf version of each report costs an additional $750 when purchased in addition to the hardcopy.

To order reports or obtain information about special pre-publication offers from within the U.S., contact sales@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Databases | Custom Research | Contact Us | Home